Literature DB >> 21965222

Total desmosines in plasma and urine correlate with lung function.

C A Lindberg1, G Engström, M Gerhardsson de Verdier, U Nihlén, M Anderson, K Forsman-Semb, M Svartengren.   

Abstract

The aim of the present study was to evaluate the relationship between the matrix degradation biomarkers, desmosine and isodesmosine (desmosines), and lung function. Plasma and creatinine-corrected urinary total desmosines (P- and U-desmosines, respectively), lung function and diffusing capacity of the lung for carbon monoxide (D(L,CO)) were measured in a cohort of subjects from the Swedish Twin Registry. Concentrations of U- and P-desmosines were measured in 349 and 318 subjects, respectively; approximately one-third of subjects had chronic obstructive pulmonary disease (COPD). Age, female sex, body mass index (BMI) and smoking were significantly associated with U-desmosines in a multiple linear regression analysis. In the overall population, after adjustments for age, sex, height, BMI and smoking, concentrations of U-desmosines were significantly correlated with all lung function measures, and P-desmosines with forced expiratory volume in 1 s and D(L,CO) (p<0.05). With the exception of residual volume versus P-desmosines, relationships between concentrations of desmosines and lung function measures were markedly stronger in subjects with COPD compared with those without COPD. These cross-sectional data showing associations between desmosines and several lung function variables suggest that desmosines, particularly U-desmosines, could be a useful biomarker of COPD status.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965222     DOI: 10.1183/09031936.00064611

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Free Desmosine is a Sensitive Marker of Smoke-Induced Emphysema.

Authors:  Jerome Cantor; Arnulfo Ochoa; Shuren Ma; Xingjian Liu; Gerard Turino
Journal:  Lung       Date:  2018-09-14       Impact factor: 2.584

2.  Free Urinary Desmosine and Isodesmosine as COPD Biomarkers: The Relevance of Confounding Factors.

Authors:  Sara Ongay; Marijke Sikma; Peter Horvatovich; Jos Hermans; Bruce E Miller; Nick H T Ten Hacken; Rainer Bischoff
Journal:  Chronic Obstr Pulm Dis       Date:  2016-03-01

3.  The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials.

Authors:  Shuren Ma; Yong Y Lin; Jerome O Cantor; Kenneth R Chapman; Robert A Sandhaus; Michael Fries; Jonathan M Edelman; Gerard McElvaney; Gerard M Turino
Journal:  Chronic Obstr Pulm Dis       Date:  2016-11-18

4.  The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes.

Authors:  Xingjian Liu; Shuren Ma; Gerard Turino; Jerome Cantor
Journal:  Lung       Date:  2016-10-19       Impact factor: 2.584

5.  Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers.

Authors:  Jelena Mustra Rakic; Siyang Zeng; Linnea Rohdin-Bibby; Erin L Van Blarigan; Xingjian Liu; Shuren Ma; John P Kane; Rita F Redberg; Gerard M Turino; Eveline Oestreicher Stock; Mehrdad Arjomandi
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

6.  The Ratio of Free to Bound Desmosine and Isodesmosine May Reflect Emphysematous Changes in COPD.

Authors:  Xingjian Liu; Shuren Ma; Sophie Liu; Ming Liu; Gerard Turino; Jerome Cantor
Journal:  Lung       Date:  2015-03-12       Impact factor: 2.584

7.  Characterization of Microfibrillar-associated Protein 4 (MFAP4) as a Tropoelastin- and Fibrillin-binding Protein Involved in Elastic Fiber Formation.

Authors:  Bartosz Pilecki; Anne T Holm; Anders Schlosser; Jesper B Moeller; Alexander P Wohl; Alexandra V Zuk; Stefanie E Heumüller; Russell Wallis; Soren K Moestrup; Gerhard Sengle; Uffe Holmskov; Grith L Sorensen
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

Review 8.  Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs.

Authors:  Gabriele Grunig; Aram Baghdassarian; Sung-Hyun Park; Serhiy Pylawka; Bertram Bleck; Joan Reibman; Erika Berman-Rosenzweig; Nedim Durmus
Journal:  Biomark Insights       Date:  2016-02-16

Review 9.  Biomarkers in chronic obstructive pulmonary disease: confusing or useful?

Authors:  Robert A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.